Françoise Beltjens

711 total citations
32 papers, 469 citations indexed

About

Françoise Beltjens is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Françoise Beltjens has authored 32 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 24 papers in Cancer Research and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Françoise Beltjens's work include Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (7 papers). Françoise Beltjens is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (7 papers). Françoise Beltjens collaborates with scholars based in France, Belgium and Gabon. Françoise Beltjens's co-authors include Laurent Arnould, Romain Boidot, Sylvain Ladoire, François Ghiringhelli, Valentin Dérangère, Aurélie Bertaut, Lionel Apétoh, J. Fraisse, Sylvain Causeret and François Martin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Françoise Beltjens

31 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Beltjens France 10 305 161 129 120 82 32 469
Angel Qin United States 12 343 1.1× 122 0.8× 94 0.7× 201 1.7× 178 2.2× 33 561
Cristina Migali Italy 12 376 1.2× 66 0.4× 198 1.5× 86 0.7× 91 1.1× 17 511
Yuka Inoue Japan 14 353 1.2× 157 1.0× 163 1.3× 86 0.7× 234 2.9× 33 569
Takuro Yukawa Japan 13 366 1.2× 98 0.6× 232 1.8× 202 1.7× 115 1.4× 37 614
Mario Liste-Hermoso United States 4 633 2.1× 298 1.9× 181 1.4× 192 1.6× 88 1.1× 7 756
Xiying Shao China 11 184 0.6× 189 1.2× 108 0.8× 85 0.7× 172 2.1× 60 462
Haihong Pu China 10 421 1.4× 187 1.2× 125 1.0× 283 2.4× 190 2.3× 16 661
Rico D. Bense Netherlands 8 298 1.0× 141 0.9× 153 1.2× 166 1.4× 177 2.2× 9 508
Zhanhuai Wang China 12 243 0.8× 170 1.1× 100 0.8× 68 0.6× 231 2.8× 24 501
Miso Kim South Korea 12 245 0.8× 91 0.6× 127 1.0× 156 1.3× 181 2.2× 30 463

Countries citing papers authored by Françoise Beltjens

Since Specialization
Citations

This map shows the geographic impact of Françoise Beltjens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Beltjens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Beltjens more than expected).

Fields of papers citing papers by Françoise Beltjens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Beltjens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Beltjens. The network helps show where Françoise Beltjens may publish in the future.

Co-authorship network of co-authors of Françoise Beltjens

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Beltjens. A scholar is included among the top collaborators of Françoise Beltjens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Beltjens. Françoise Beltjens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertaut, Aurélie, Sylvain Ladoire, Isabelle Desmoulins, et al.. (2024). HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity. Cancers. 16(11). 2009–2009. 1 indexed citations
2.
Truntzer, Caroline, David Rageot, Françoise Beltjens, et al.. (2024). Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery. Biomedicines. 12(12). 2754–2754. 1 indexed citations
3.
Presles, Benoît, Charles Coutant, Isabelle Desmoulins, et al.. (2024). Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer. EJNMMI Research. 14(1). 60–60. 3 indexed citations
4.
Bertaut, Aurélie, Françoise Beltjens, Céline Charon‐Barra, et al.. (2023). Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers. British Journal of Cancer. 129(1). 122–134. 27 indexed citations
5.
Arnould, Laurent, Françoise Beltjens, Didier Mayeur, et al.. (2023). Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy. Breast Cancer. 30(6). 997–1007. 8 indexed citations
6.
Beltjens, Françoise, et al.. (2023). Abstract P5-01-11: Utility of 18F-FDG PET/CT for the prediction of pathologic complete response in axilla to neoadjuvant chemotherapy in breast cancer. Cancer Research. 83(5_Supplement). P5–1. 1 indexed citations
7.
Jankowski, Clémentine, Laura Vincent, Françoise Beltjens, et al.. (2023). Axillary pathologic response after neoadjuvant chemotherapy and surgery according to breast cancers subtypes and survival impact. Bulletin du Cancer. 110(6). 605–615. 5 indexed citations
8.
Chevrier, Sandy, Angélique Chevriaux, Caroline Truntzer, et al.. (2022). Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use. International Journal of Molecular Medicine. 49(5). 3 indexed citations
9.
Beltjens, Françoise, Aurélie Bertaut, Corentin Richard, et al.. (2021). ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer. International Journal of Cancer. 149(1). 200–213. 17 indexed citations
10.
MacGrogan, Gaëtan, Aurélie Bertaut, Sylvain Ladoire, et al.. (2021). Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations. Modern Pathology. 34(7). 1282–1296. 23 indexed citations
11.
Bertaut, Aurélie, Françoise Beltjens, Isabelle Desmoulins, et al.. (2021). Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort. Bulletin du Cancer. 109(3). 268–279. 3 indexed citations
12.
Desmoulins, Isabelle, Françoise Beltjens, Sylvain Causeret, et al.. (2020). An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing. Journal of Clinical Pathology. 73(9). 597–601. 2 indexed citations
13.
Cancel, Mathilde, T. Charles, François Rozet, et al.. (2020). Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression. Urologic Oncology Seminars and Original Investigations. 39(1). 74.e17–74.e23. 5 indexed citations
14.
Chevrier, Sandy, Françoise Beltjens, Magalie Dosset, et al.. (2019). Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance. Cancer Research. 79(23). 5958–5970. 69 indexed citations
15.
Riedinger, Jean‐Marc, Vincent Goussot, Isabelle Desmoulins, et al.. (2016). ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3. Bulletin du Cancer. 103(5). 434–443. 5 indexed citations
16.
Beltjens, Françoise, Aurélie Bertaut, Catherine Loustalot, et al.. (2015). HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stable. European Journal of Cancer Care. 26(2). e12404–e12404. 6 indexed citations
18.
Hennequin, Audrey, Valentin Dérangère, Romain Boidot, et al.. (2015). Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients. OncoImmunology. 5(2). e1054598–e1054598. 165 indexed citations
19.
Beltjens, Françoise, et al.. (2015). Une pancréatite auto-immune à IgG4 simulant un adénocarcinome : à propos d’un cas. Annales de Pathologie. 35(6). 511–514. 3 indexed citations
20.
Bertaut, Aurélie, Delphine Hudry, Françoise Beltjens, et al.. (2015). About invasive cervical cancer: a French population based study between 1998 and 2010. European Journal of Obstetrics & Gynecology and Reproductive Biology. 191. 1–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026